Autologous dendritic cell vaccination (DCVAC/PCa) added to docetaxel chemotherapy in a double-blind, randomized phase III trial (VIABLE) in men with advanced (mCRPC) prostate cancer.
/in Dendritic Cells, International Publications, Prostate Cancer /von 2015-05-30 / J Clin Oncol 33, 2015 (suppl; abstr TPS5070)Long-term follow-up of patients with acute myelogenous leukemia receiving an autologous telomerase-based dendritic cell vaccine.
/in Acute Leukemia, Dendritic Cells, International Publications /von 2015-05-30 / J Clin Oncol 33, 2015 (suppl; abstr 7007)A study of mature alpha-DC-1 vaccine to induce immune responses in ovarian cancer.
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2015-05-29 / J Clin Oncol 33, 2015 (suppl; abstr e14033)Dendritic Cell-Based Vaccines that Utilize Myeloid Rather than Plasmacytoid Cells Offer a Superior Survival Advantage in Malignant Glioma
/in Dendritic Cells, Glioblastoma, International Publications /von 2015-05-29 / J. Immunol. 2015 Jul;195(1):367-76Long-term survival of a breast cancer patient with extensive liver metastases upon immune and virotherapy: a case report
/in Breast Cancer, Dendritic Cells, Hyperthermia, International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2015-05-28 / Immunotherapy 2015;7(8):855-60Hyperthermia combined with 5-fluorouracil promoted apoptosis and enhanced thermotolerance in human gastric cancer cell line SGC-7901
/in Gastric Cancer, Hyperthermia, International Publications /von 2015-05-27 / Onco Targets Ther 2015;8:1265-70Local hyperthermia combined with radiotherapy and-/or chemotherapy: recent advances and promises for the future
/in Hyperthermia, International Publications /von 2015-05-27 / Cancer Treat. Rev. 2015 Nov;41(9):742-53Gastric cancer and the epoch of immunotherapy approaches
/in Dendritic Cells, Gastric Cancer, International Publications /von 2015-05-21 / World J. Gastroenterol. 2015 May;21(19):5778-93Dendritic cell-based vaccination in cancer: therapeutic implications emerging from murine models
/in Dendritic Cells, International Publications /von 2015-05-20 / Front Immunol 2015;6:243
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution